Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Value Type description Interaction Map Network Comparison Type Rank Gene red Filtered green network_comparison
Results: HTML CSV LaTeX Showing element 2262 to 2311 of 3228 in total 
Value Type: Measured
Interaction Map: High confidence
Network Comparison Type: Divided
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
putative nadh oxidoreductase complex i subunit homolog. [source:sptrembl;acc:q96q80]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3146\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
putative nucleoside diphosphate kinase (ec 2.7.4.6) (ndk) (ndp kinase). [source:swissprot;acc:o60361]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
637\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7756.51\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8731.76\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.12573\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
putative phosphoglycerate mutase 3 (ec 5.4.2.1) (ec 5.4.2.4) (ec 3.1.3.13). [source:swissprot;acc:q8n0y7]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1112\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5910.54\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6440.58\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08968\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
putative pre-mrna splicing factor rna helicase (atp-dependent rna helicase #3) (deah-box protein 16). [source:swissprot;acc:o60231]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2319\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6362.48\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6647.42\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04478\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
putative pre-mrna splicing factor rna helicase (deah box protein 15) (atp-dependent rna helicase #46). [source:swissprot;acc:o43143]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
349\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4714.85\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5554.38\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.17806\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
putative ribosomal rna methyltransferase 1 (ec 2.1.1.-) (rrna (uridine-2'-o-)-methyltransferase) (jm23 protein). [source:swissprot;acc:q9uet6]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1607\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5232.99\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5606.53\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07138\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
putative rna-binding protein 15 (rna binding motif protein 15) (one-twenty two protein). [source:swissprot;acc:q96t37]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
276\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3119.98\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2579.49\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.20953\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
putative rna-binding protein 7 (rna binding motif protein 7). [source:swissprot;acc:q9y580]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2134\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5328.73\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5616.59\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05402\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
putative sialoglycoprotease type 2. [source:refseq;acc:nm\_022353]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
992\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5393.37\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5909.47\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09569\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
putative tumor suppressor 101f6. [source:refseq;acc:nm\_007022]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3051\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
pwwp domain containing 1; hdgf (hepatoma-derived growth factor) like. [source:refseq;acc:nm\_138574]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
388\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4533.74\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5279.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.16447\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
pxr2b protein. [source:refseq;acc:nm\_016559]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1929\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6996.51\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7429.18\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06184\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
pyridoxine 5'-phosphate oxidase. [source:refseq;acc:nm\_018129]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1272\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5528.65\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5985.58\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08265\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
pyrroline 5-carboxylate reductase isoform. [source:refseq;acc:nm\_013328]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
487\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5277.4\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6042.88\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.14505\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
pyrroline-5-carboxylate reductase (ec 1.5.1.2) (p5cr) (p5c reductase). [source:swissprot;acc:p32322]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
489\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5281.11\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6044.61\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.14457\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
pyruvate carboxylase, mitochondrial precursor (ec 6.4.1.1) (pyruvic carboxylase) (pcb). [source:swissprot;acc:p11498]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
786\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
9304.83\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10347.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11204\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
pyruvate dehydrogenase e1 component alpha subunit, somatic form, mitochondrial precursor (ec 1.2.4.1) (pdhe1-a type i). [source:swissprot;acc:p08559]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2540\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6672.69\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6827.51\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0232\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
pyruvate dehydrogenase e1 component alpha subunit, testis-specific form, mitochondrial precursor (ec 1.2.4.1) (pdhe1-a type ii). [source:swissprot;acc:p29803]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2537\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6669.22\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6824.41\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02327\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
pyruvate dehydrogenase e1 component beta subunit, mitochondrial precursor (ec 1.2.4.1) (pdhe1-b). [source:swissprot;acc:p11177]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2450\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6737.15\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6957.34\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03268\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
pyruvate kinase, m1 isozyme (ec 2.7.1.40) (pyruvate kinase muscle isozyme) (cytosolic thyroid hormone-binding protein) (cthbp) (thbp1). [source:swissprot;acc:p14618]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1806\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4783.49\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5097.66\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06568\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
quaking isoform 6. [source:sptrembl;acc:q9p0x9]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2224\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5864.49\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6145.14\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04786\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
r3h domain (binds single-stranded nucleic acids) containing-like. [source:refseq;acc:nm\_178491]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3132\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
r3h domain protein 1. [source:swissprot;acc:q15032]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2080\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5837.34\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6162.91\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05577\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
rab acceptor 1 (prenylated); prenylated rab acceptor 1. [source:refseq;acc:nm\_006423]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1137\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5790.65\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6303.92\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08864\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
rab coupling protein; rab-interacting recycling protein; rab effector protein; rab11-family interacting protein 1. [source:refseq;acc:nm\_025151]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1449\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5602.01\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6031.05\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07659\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
rab gdp dissociation inhibitor alpha (rab gdi alpha) (gdi-1) (xap-4) (oligophrenin 2). [source:swissprot;acc:p31150]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3119\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
rab gdp dissociation inhibitor beta (rab gdi beta) (gdi-2). [source:swissprot;acc:p50395]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3193\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
rab geranylgeranyltransferase alpha subunit (ec 2.5.1.-) (rab geranyl- geranyltransferase alpha subunit) (rab gg transferase alpha) (rab ggtase alpha). [source:swissprot;acc:q92696]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3134\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
rab3a interacting protein (rabin3)-like 1. [source:refseq;acc:nm\_013401]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1109\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6545.19\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7132.89\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08979\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
rab3a interacting protein isoform alpha 1; rabin3; ssx2 interacting protein. [source:refseq;acc:nm\_022456]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1111\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6540.61\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7127.41\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08972\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
rabaptin, rab gtpase binding effector protein 1; rabaptin-5; neurocrescin. [source:refseq;acc:nm\_004703]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1737\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5925.65\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6326.43\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06763\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
rac gtpase activating protein 1; gtpase activating protein. [source:refseq;acc:nm\_013277]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1941\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5521.07\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5856.93\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06083\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
rac-alpha serine/threonine kinase (ec 2.7.1.-) (rac-pk-alpha) (protein kinase b) (pkb) (c-akt). [source:swissprot;acc:p31749]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
542\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
3889.27\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
4426.74\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.13819\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
rac-beta serine/threonine protein kinase (ec 2.7.1.-) (rac-pk-beta) (protein kinase akt-2) (protein kinase b, beta) (pkb beta). [source:swissprot;acc:p31751]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
545\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
rac-gamma serine/threonine protein kinase (ec 2.7.1.-) (rac-pk-gamma) (protein kinase akt-3) (protein kinase b, gamma) (pkb gamma) (stk-2). [source:swissprot;acc:q9y243]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
544\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
rad1 homolog isoform 1; exonuclease homolog rad1; cell cycle checkpoint protein rad1 a/b; rad1-like protein; cell cycle checkpoint protein hrad1; dna repair exonuclease (rec1); dna repair protein rad1; rad1-like dna damage checkpoint protein. [source:refseq;acc:nm\_002853]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2111\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6916.14\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7295.24\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05481\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
rad17 homolog isoform 1; rad17-like protein; cell cycle checkpoint protein (rad17); rf-c activator 1 homolog. [source:refseq;acc:nm\_002873]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1837\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5739.49\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6108.72\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06433\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
rad50 homolog isoform 1. [source:refseq;acc:nm\_005732]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2601\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7222.12\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7110.74\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01566\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
rad50-interacting protein 1. [source:refseq;acc:nm\_021930]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
450.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2394.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5.31521\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
rad54-like protein; rad54 homolog. [source:refseq;acc:nm\_003579]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1260\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5754.84\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6232.83\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08306\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
rad9 homolog; cell cycle checkpoint control protein; rad9 homolog (s. pombe). [source:refseq;acc:nm\_004584]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2027\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6218.34\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6575.81\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05749\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
raf proto-oncogene serine/threonine-protein kinase (ec 2.7.1.-) (raf-1) (c-raf). [source:swissprot;acc:p04049]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
193\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
17756.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
14007.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.26766\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ral guanine nucleotide dissociation stimulator (ralgef) (ralgds). [source:swissprot;acc:q12967]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
267\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
14021.4\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11523\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.21682\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ral guanine nucleotide dissociation stimulator-like 1 (ralgds-like 1). [source:swissprot;acc:q9nzl6]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
295\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
13261.9\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11017.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.20368\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ral guanine nucleotide dissociation stimulator-like 2 (ralgds-like factor) (ras-associated protein rab2l). [source:swissprot;acc:o15211]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
217\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
16071.6\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
12886.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.24714\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ral guanine nucleotide exchange factor ralgps1a. [source:refseq;acc:nm\_014636]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2347\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6480.27\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6765.81\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.04406\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
ral-a exchange factor ralgps2. [source:refseq;acc:nm\_152663]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2348\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
rala binding protein 1; rala-binding protein. [source:refseq;acc:nm\_006788]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3212\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ran binding protein 11. [source:refseq;acc:nm\_016338]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1032\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6138.91\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6717.05\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09418\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ran binding protein 3 isoform ranbp3-d; ran-binding protein-3. [source:refseq;acc:nm\_007322]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3202\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/